Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q5E9K3

Entry ID Method Resolution Chain Position Source
AF-Q5E9K3-F1 Predicted AlphaFoldDB

43 variants for Q5E9K3

Variant ID(s) Position Change Description Diseaes Association Provenance
rs465341082 8 V>G No EVA
rs438244030 9 I>M No EVA
rs467993041 12 F>L No EVA
rs447359216 16 A>D No EVA
rs477058972 18 W>G No EVA
rs443500488 20 R>G No EVA
rs482964414 20 R>L No EVA
rs461019716 21 C>F No EVA
rs461019716 21 C>S No EVA
rs442559788 23 R>H No EVA
rs454099028 24 H>L No EVA
rs472531093 24 H>N No EVA
rs454099028 24 H>R No EVA
rs438851049 27 S>R No EVA
rs876518029 33 D>G No EVA
rs468079924 41 Y>* No EVA
rs438326859 41 Y>F No EVA
rs434190331 44 D>E No EVA
rs876092346 44 D>G No EVA
rs467134467 45 P>T No EVA
rs209082761 57 D>N No EVA
rs469403976 108 R>C No EVA
rs469403976 108 R>S No EVA
rs454098140 126 F>L No EVA
rs441698806 127 A>D No EVA
rs1115548764 146 V>M No EVA
rs134147767 157 Y>S No EVA
rs460933394 159 H>P No EVA
rs442925271 160 S>A No EVA
rs442925271 160 S>P No EVA
rs472726838 162 P>R No EVA
rs460533892 164 S>R No EVA
rs438759374 171 V>F No EVA
rs799209105 179 P>L No EVA
rs456839104 180 D>Y No EVA
rs452819642 186 K>T No EVA
rs478344004 207 G>D No EVA
rs444425030 208 G>A No EVA
rs480587514 209 Y>N No EVA
rs462462243 212 Y>S No EVA
rs134951409 224 N>T No EVA
rs440654356 239 G>V No EVA
rs473630796 248 H>P No EVA

No associated diseases with Q5E9K3

3 regional properties for Q5E9K3

Type Name Position InterPro Accession
domain Pyridoxamine 5'-phosphate oxidase, putative 73 - 153 IPR011576
domain Pyridoxine 5'-phosphate oxidase, dimerisation, C-terminal 206 - 261 IPR019576
conserved_site Pyridoxamine 5'-phosphate oxidase, conserved site 216 - 229 IPR019740

Functions

Description
EC Number 1.4.3.5 With oxygen as acceptor
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

4 GO annotations of molecular function

Name Definition
FMN binding Binding to flavin mono nucleotide. Flavin mono nucleotide (FMN) is the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.
protein homodimerization activity Binding to an identical protein to form a homodimer.
pyridoxal phosphate binding Binding to pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6.
pyridoxamine-phosphate oxidase activity Catalysis of the reaction: pyridoxamine 5'-phosphate + H2O + O2 = pyridoxal 5'-phosphate + NH3 + hydrogen peroxide.

2 GO annotations of biological process

Name Definition
pyridoxal phosphate biosynthetic process The chemical reactions and pathways resulting in the formation of pyridoxal phosphate, pyridoxal phosphorylated at the hydroxymethyl group of C-5, the active form of vitamin B6.
pyridoxine biosynthetic process The chemical reactions and pathways resulting in the formation of pyridoxine, 2-methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine, one of the vitamin B6 compounds.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P38075 PDX3 Pyridoxamine 5'-phosphate oxidase Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q9NVS9 PNPO Pyridoxine-5'-phosphate oxidase Homo sapiens (Human) PR
Q9ZPY1 PPOX2 Pyridoxine/pyridoxamine 5'-phosphate oxidase 2 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MIFWLRSVIV TFGRPAEWPR CLRHLCSRGA AMDLGPMRKT YRGDPEAFEE THLTSLDPVK
70 80 90 100 110 120
QFAAWFEEAV QCPDIMEANA MCLATCTRDG KPSARMVLLK GFGKDGFRFF TNFESRKGKE
130 140 150 160 170 180
LDSNPFASLV FYWEPLHRQV RVEGPVKKLP EEEAECYFHS RPKSSQIGAV VSHQSSVIPD
190 200 210 220 230 240
REYLRKKNKE LEQLYQEQEV PKPKYWGGYI LYPQVMEFWQ GQTNRLHDRI VFRRGLLTGD
250 260
SPLGPMTHRG EEDWVYERLA P